Chemoinformaics analysis of 8-O-methylretusin
| Molecular Weight | 298.294 | nRot | 3 |
| Heavy Atom Molecular Weight | 284.182 | nRig | 18 |
| Exact Molecular Weight | 298.084 | nRing | 3 |
| Solubility: LogS | -4.008 | nHRing | 1 |
| Solubility: LogP | 3.09 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 41.7351 |
| nHD | 1 | BPOL | 20.1209 |
| QED | 0.804 |
| Synth | 2.165 |
| Natural Product Likeliness | 0.947 |
| NR-PPAR-gamma | 0.642 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.02 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.633 |
| MDCK | 0.0000252 |
| BBB | 0.063 |
| PPB | 0.937065 |
| VDSS | 0.438 |
| FU | 0.0621098 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.899 |
| CYP2c19-inh | 0.764 |
| CYP2c19-sub | 0.084 |
| CYP2c9-inh | 0.796 |
| CYP2c9-sub | 0.92 |
| CYP2d6-inh | 0.637 |
| CYP2d6-sub | 0.903 |
| CYP3a4-inh | 0.659 |
| CYP3a4-sub | 0.332 |
| CL | 5.067 |
| T12 | 0.579 |
| hERG | 0.072 |
| Ames | 0.272 |
| ROA | 0.283 |
| SkinSen | 0.575 |
| Carcinogencity | 0.659 |
| EI | 0.549 |
| Respiratory | 0.536 |
| NR-Aromatase | 0.831 |
| Antiviral | Yes |
| Prediction | 0.812642 |